Crohn's Disease Clinical Trials

993 clinical trials for Crohn's Disease across international registries, including 139 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting — RECRUITING · PHASE4
• An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab — RECRUITING · PHASE1
• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease — RECRUITING · PHASE4
• Behavioral Therapy for Crohn's Disease — RECRUITING · NA
• VIBRANT-IBD: Brain Effects of Non-Invasive Vagus Nerve Stimulation in IBD Remission — RECRUITING · PHASE1
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) — RECRUITING · PHASE3
• A Clinical Decision Support Tool (CDST) for Vedolizumab (VDZ) in Patients with Crohn’s Disease – a German Chart Review — RECRUITING
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) — RECRUITING · PHASE3
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease — RECRUITING · PHASE3
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight — RECRUITING · PHASE3
• Zymfentra (Infliximab-dyyb) REal World Cohort STudy — RECRUITING
• Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease — RECRUITING
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn’s Disease — RECRUITING · PHASE3
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease — RECRUITING · PHASE3
• Methotrexate in paediatric and adolescent Crohn’s disease: an observational study — RECRUITING · PHASE4
• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE2
• Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD) — RECRUITING · NA
• Real-World Study of IL-23 Inhibitors in Active Crohn's Disease — RECRUITING
• Stopping PPI Therapy in Inactive IBD — RECRUITING · PHASE4
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE2
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3
• A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK) — RECRUITING
• A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany — RECRUITING
• Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD — RECRUITING · NA
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3
• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease — RECRUITING · PHASE2
• A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting — RECRUITING
• Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3
• A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) — RECRUITING · PHASE3
• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3
• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. — RECRUITING · PHASE2
• Enabling Microbiomics- Driven Personalized Nutrition — RECRUITING
• Repetitive Transcranial Magnetic Stimulation Combined With Anti-inflammatory Diet in Crohn's Disease — RECRUITING · NA
• A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3
• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease — RECRUITING · PHASE3
• A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) — RECRUITING · PHASE2
• A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS) — RECRUITING · PHASE2
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, AND ACTIVE-CONTROLLED MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF JNJ-78934804 IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE — RECRUITING · PHASE3
• Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis — RECRUITING · NA
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) — RECRUITING · PHASE3
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) — RECRUITING · PHASE3
• Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. — RECRUITING · PHASE4
• Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis — RECRUITING · NA
• Fecal Microbiome Transplant — RECRUITING · PHASE1
• Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study — RECRUITING · NA
• Subcutaneous infliximab in patients with chronic inflammatory bowel disease and previous immunogenic failure under intravenous infliximab (IMMUNO-FIX) — RECRUITING
• Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients. — RECRUITING · PHASE3
• A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease — RECRUITING · PHASE2
• A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting — RECRUITING
• A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3

Refine this search